Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series

由 Stravodimou, Athina, Zaman, Khalil, Voutsadakis, Ioannis A.
出版 2014

Severe Peritonitis Induced by Methotrexate During Treatment of Persistent Gestational Trophoblastic Disease

由 Zimmermann, Stefan, Zaman, Khalil, Wolfer, Anita, Jacot, William
出版 2012

Expert Discussion: Immunotherapy in Breast Cancer − Ready for Prime Time?

由 Rinnerthaler, Gabriel, Müller, Volkmar, Balic, Marija, Zaman, Khalil, Dieci, Maria Vittoria
發表在 Breast Care (Basel) (2021)

Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials” (Galvano...

由 Gonzalez-Rodriguez, Elena, Aubry-Rozier, Bérengère, Stoll, Delphine, Zaman, Khalil, Lamy, Olivier
發表在 J Bone Oncol (2020)

Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma

由 Wavre, Aurelia, Baur, Audrey S., Betz, Michael, Mühlematter, Dominique, Jotterand, Martine, Zaman, Khalil, Ketterer, Nicolas
出版 2007

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity

由 Tsoutsou, Pelagia G., Zaman, Khalil, Martin Lluesma, Silvia, Cagnon, Laurene, Kandalaft, Lana, Vozenin, Marie-Catherine
發表在 Front Oncol (2018)

Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre

由 Jermini, Mégane, Dubois, Julie, Rodondi, Pierre-Yves, Zaman, Khalil, Buclin, Thierry, Csajka, Chantal, Orcurto, Angela, Rothuizen, Laura E.
發表在 Sci Rep (2019)

Intraductal patient‐derived xenografts of estrogen receptor α‐positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions

由 Fiche, Maryse, Scabia, Valentina, Aouad, Patrick, Battista, Laura, Treboux, Assia, Stravodimou, Athina, Zaman, Khalil, Dormoy, Valerian, Ayyanan, Ayyakkannu, Sflomos, George, Brisken, Cathrin
發表在 J Pathol (2018)

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

由 Schmid, Sabine, Klingbiel, Dirk, Aebi, Stefan, Goldhirsch, Aron, Mamot, Christoph, Munzone, Elisabetta, Nolè, Franco, Oehlschlegel, Christian, Pagani, Olivia, Pestalozzi, Bernhard, Rochlitz, Christoph, Thürlimann, Beat, von Moos, Roger, Weder, Patrik, Zaman, Khalil, Ruhstaller, Thomas
發表在 BMC Cancer (2019)

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

由 DeCensi, Andrea, Sun, Zhuoxin, Guerrieri-Gonzaga, Aliana, Thürlimann, Beat, McIntosh, Christina, Tondini, Carlo, Monnier, Alain, Campone, Mario, Debled, Marc, Schönenberger, Astrid, Zaman, Khalil, Johansson, Harriet, Price, Karen N., Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Aebi, Stefan
出版 2014

Phase III trial (EORTC 10994/BIG 1-00) assessing the value of p53 using a functional assay to predict sensitivity to a taxane versus non taxane primary chemotherapy in breast cance...

由 Bonnefoi, Hervé, Piccart, Martine, Bogaerts, Jan, Mauriac, Louis, Fumoleau, Pierre, Brain, Etienne, Petit, Thierry, Rouanet, Philippe, Jassem, Jacek, Blot, Emmanuel, Zaman, Khalil, Cufer, Tanja, Lortholary, Alain, Lidbrink, Elisabet, André, Sylvie, Litière, Saskia, Lago, Lissandra Dal, Becette, Véronique, Cameron, David A., Bergh, Jonas, Iggo, Richard
出版 2011

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collecti...

由 Bandiera, Carole, Cardoso, Evelina, Locatelli, Isabella, Digklia, Antonia, Zaman, Khalil, Diciolla, Antonella, Cristina, Valérie, Stravodimou, Athina, Veronica, Aedo Lopez, Dolcan, Ana, Sarivalasis, Apostolos, Liapi, Aikaterini, Bouchaab, Hasna, Orcurto, Angela, Dotta-Celio, Jennifer, Peters, Solange, Decosterd, Laurent, Widmer, Nicolas, Wagner, Dorothea, Csajka, Chantal, Schneider, Marie Paule
發表在 JMIR Res Protoc (2021)

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-neg...

由 Rochlitz, Christoph, Bigler, Martin, von Moos, Roger, Bernhard, Jürg, Matter-Walstra, Klazien, Wicki, Andreas, Zaman, Khalil, Anchisi, Sandro, Küng, Marc, Na, Kyung-Jae, Bärtschi, Daniela, Borner, Markus, Rordorf, Tamara, Rauch, Daniel, Müller, Andreas, Ruhstaller, Thomas, Vetter, Marcus, Trojan, Andreas, Hasler-Strub, Ursula, Cathomas, Richard, Winterhalder, Ralph
發表在 BMC Cancer (2016)

Angiogenic Activity of Breast Cancer Patients’ Monocytes Reverted by Combined Use of Systems Modeling and Experimental Approaches

由 Guex, Nicolas, Crespo, Isaac, Bron, Sylvian, Ifticene-Treboux, Assia, Faes-van’t Hull, Eveline, Kharoubi, Solange, Liechti, Robin, Werffeli, Patricia, Ibberson, Mark, Majo, Francois, Nicolas, Michäel, Laurent, Julien, Garg, Abhishek, Zaman, Khalil, Lehr, Hans-Anton, Stevenson, Brian J., Rüegg, Curzio, Coukos, George, Delaloye, Jean-François, Xenarios, Ioannis, Doucey, Marie-Agnès
發表在 PLoS Comput Biol (2015)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

由 Phillips, Kelly-Anne, Regan, Meredith M, Ribi, Karin, Francis, Prudence A, Puglisi, Fabio, Bellet, Meritxell, Spazzapan, Simon, Karlsson, Per, Budman, Daniel R, Zaman, Khalil, Abdi, Ehtesham A, Domchek, Susan M, Feng, Yang, Price, Karen N, Coates, Alan S, Gelber, Richard D, Maruff, Paul, Boyle, Frances, Forbes, John F, Ahles, Tim, Fleming, Gini F, Bernhard, Jürg
發表在 Br J Cancer (2016)

Oncological care organisation during COVID-19 outbreak

由 Onesti, Concetta Elisa, Rugo, Hope S, Generali, Daniele, Peeters, Marc, Zaman, Khalil, Wildiers, Hans, Harbeck, Nadia, Martin, Miguel, Cristofanilli, Massimo, Cortes, Javier, Tjan-Heijnen, Vivianne, Hurvitz, Sara A, Berchem, Guy, Tagliamento, Marco, Campone, Mario, Bartsch, Rupert, De Placido, Sabino, Puglisi, Fabio, Rottey, Sylvie, Müller, Volkmar, Ruhstaller, Thomas, Machiels, Jean-Pascal, Conte, PierFranco, Awada, Ahmad, Jerusalem, Guy
發表在 ESMO Open (2020)

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

由 Ruhstaller, Thomas, Giobbie-Hurder, Anita, Colleoni, Marco, Jensen, Maj-Britt, Ejlertsen, Bent, de Azambuja, Evandro, Neven, Patrick, Láng, István, Jakobsen, Erik Hugger, Gladieff, Laurence, Bonnefoi, Hervé, Harvey, Vernon J., Spazzapan, Simon, Tondini, Carlo, Del Mastro, Lucia, Veyret, Corinne, Simoncini, Edda, Gianni, Lorenzo, Rochlitz, Christoph, Kralidis, Elena, Zaman, Khalil, Jassem, Jacek, Piccart-Gebhart, Martine, Di Leo, Angelo, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron, Thürlimann, Beat, Regan, Meredith M.
發表在 J Clin Oncol (2019)